Investor insights
Sectors invested in
Funding rounds participated in
$6M sweet spot round size
Most of their 25 investments are in rounds between $2.5M and $18M
Investor type
Basic info
Industry
Sectors
Date founded
2006
Investments made
CellFE - Cell Fluidics Engineering raised $22M on September 27, 2023
Investors: GreatPoint Ventures, Riverine Ventures, Khosla Ventures, Embark Ventures, M Ventures, Cota Capital and Elm Street Ventures
P2 Science, Inc. raised undisclosed on February 23, 2023
Investors: Safer Made, CHANEL, Lewis & Clark AgriFood, Heritage Group and Elm Street Ventures
Cybrexa Therapeutics raised $25M on March 10, 2021
Investors: Advantage Capital, HighCape Partners and Elm Street Ventures
Artizan Biosciences, Inc. raised $19M on March 1, 2021
Investors: Biohaven Pharmaceuticals, Osage University Partners (OUP) and Elm Street Ventures
P2 Science, Inc. raised $12M on January 29, 2020
Investors: HG Ventures, Ironwood Capital, Xeraya Capital, CHANEL, Advantage Capital and Elm Street Ventures
CellFE - Cell Fluidics Engineering raised $4.8M on January 16, 2020
Investors: Cota Capital, Creative Destruction Lab, Embark Ventures and Elm Street Ventures
EvolveImmune Therapeutics raised $18M on January 8, 2020
Investors: Takeda UK Limited, Solasta Ventures and Elm Street Ventures
Artizan Biosciences, Inc. raised $12M on June 11, 2019
Investors: Marin Investments Limited, Brii Biosciences, Osage University Partners (OUP) and Elm Street Ventures
Halda Therapeutics raised $25M on February 1, 2019
Investors: 6 Dimensions Capital, Canaan and Elm Street Ventures
Iconic Therapeutics, Inc. raised $4.1M on June 15, 2018
Investors: H.I.G. BioVentures, Lundbeckfonden / Lundbeck Foundation, MPM Capital, JLABS, HBM Partners AG, Osage University Partners (OUP) and Elm Street Ventures